Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GALVANATOR 725

K-Number: K810057 · 1981-01-23

Decision Date1981-01-23
Product CodeIPF
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

GALVANATOR 725 is the device name listed in this FDA 510(k) record. The listed applicant is Avratronics Corp.. It received FDA 510(k) clearance on 1981-01-23 under 510(k) number K810057. The device is classified under product code IPF. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GALVANATOR 725?

GALVANATOR 725 is a medical device that received FDA 510(k) clearance on 1981-01-23. The listed applicant is Avratronics Corp.. The 510(k) number is K810057.

When did GALVANATOR 725 receive FDA 510(k) clearance?

GALVANATOR 725 received FDA 510(k) clearance on 1981-01-23, under 510(k) number K810057.

Who is the listed applicant for GALVANATOR 725?

The FDA 510(k) record lists Avratronics Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GALVANATOR 725?

The FDA product code for GALVANATOR 725 is IPF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Avratronics Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: IPF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑